|
|
Volumn 24, Issue 3, 2006, Pages 330-331
|
|
Intensive surveillance after stage II or III colorectal cancer: Is it worth it?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
ANTINEOPLASTIC AGENT;
ANAMNESIS;
ANXIETY;
BLOOD CELL COUNT;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLONOSCOPY;
COLORECTAL CANCER;
COMBINATION CHEMOTHERAPY;
COMPUTER ASSISTED TOMOGRAPHY;
ECHOGRAPHY;
EDITORIAL;
FOLLOW UP;
HUMAN;
LIVER FUNCTION TEST;
MEDICAL DECISION MAKING;
METASTASIS;
MINIMAL RESIDUAL DISEASE;
NON INVASIVE MEASUREMENT;
PATIENT MONITORING;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
THORAX RADIOGRAPHY;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
EARLY DIAGNOSIS;
HEALTH SURVEY;
METHODOLOGY;
MORTALITY;
NOTE;
PATHOLOGY;
PREDICTION AND FORECASTING;
RANDOMIZED CONTROLLED TRIAL;
SPAIN;
SURVIVAL;
TIME;
TUMOR RECURRENCE;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
COLONOSCOPY;
COLORECTAL NEOPLASMS;
DISEASE-FREE SURVIVAL;
EARLY DIAGNOSIS;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
POPULATION SURVEILLANCE;
PREDICTIVE VALUE OF TESTS;
RANDOMIZED CONTROLLED TRIALS;
SPAIN;
SURVIVAL ANALYSIS;
TIME FACTORS;
UNITED STATES;
|
|
EID: 33644838966
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.03.8323 Document Type: Editorial |
|
Times cited : (21)
|
|
References (8)
|
